CRSP
CRISPR Therapeutics AG
Stock
$55.43−0.01 (−0.02%)Close Oct 2, 2026
- EBITDA, 2025
- −$645M
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | −$645M | — |
| 2024 | −$447M | — |
| 2023 | −$203M | — |
| 2022 | −$649M | — |
| 2021 | $391M | — |
| 2020 | −$345M | — |
| 2019 | $51M | — |
| 2018 | −$155M | — |
| 2017 | −$62M | — |
| 2016 | −$67M | — |
| 2015 | −$26M | — |
| 2014 | −$6.6M | — |